An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)
Clinical trial NCT01990248 · COMPLETED
Trial details
- NCT number
- NCT01990248
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-03-23
- Primary completion
- 2016-07-26
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.